Get started
Author

Maria S. Asdourian

Observed names: M. Asdourian, M.S. Asdourian, MS Asdourian, Maria Asdourian, Maria S Asdourian
Observed institutions: Boston University, Boston Medical Center, Boston Children's Hospital, Harvard University, Massachusetts General Hospital, Mass General Brigham
OpenAlex ID: A5113856004
Timing of Lymphedema After Treatment for Breast Cancer: When Are Patients Most At Risk?
2018 · Susan G.R. McDuff, Amir I. Mina, et al. · International Journal of Radiation Oncology*Biology*Physics · 190
Mobile zinc increases rapidly in the retina after optic nerve injury and regulates ganglion cell survival and optic nerve regeneration
2017 · Yiqing Li, Lukas Andereggen, et al. · Proceedings of the National Academy of Sciences · 163
PDF
Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis
2016 · Maria S Asdourian, Melissa N Skolny, et al. · The Lancet Oncology · 118
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer
2022 · Maria S. Asdourian, Nishi Shah, et al. · JAMA Dermatology · 84
Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions
2017 · Hoda E. Sayegh, Maria S. Asdourian, et al. · Current Breast Cancer Reports · 82
Association Between Precautionary Behaviors and Breast Cancer–Related Lymphedema in Patients Undergoing Bilateral Surgery
2017 · Maria S. Asdourian, Meyha N. Swaroop, et al. · Journal of Clinical Oncology · 71
A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema
2016 · Cara Seward, Melissa Skolny, et al. · Journal of Surgical Oncology · 62
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
2022 · Ted V. Jacoby, Nishi Shah, et al. · Journal of the American Academy of Dermatology · 14
PDF
Hand Edema in Patients at Risk of Breast Cancer–Related Lymphedema: Health Professionals Should Take Notice
2018 · Cheryl L Brunelle, Meyha N Swaroop, et al. · Physical Therapy · 8
PDF
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
2023 · Michael R. Stephens, Maria S. Asdourian, et al. · Journal of the American Academy of Dermatology · 7
PDF
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
2022 · Maria S. Asdourian, Tracey S. Otto, et al. · Journal of the American Academy of Dermatology · 7
PDF
Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist
2022 · Nishi Shah, Maria S. Asdourian, et al. · Current Dermatology Reports · 6
PDF
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
2022 · Maria S. Asdourian, Nishi Shah, et al. · Journal of the American Academy of Dermatology · 6
Dercum's disease: A retrospective cohort study
2022 · Maria S. Asdourian, Nishi Shah, et al. · Journal of the American Academy of Dermatology · 5
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
2023 · Maria S. Asdourian, Ted V. Jacoby, et al. · Journal of the American Academy of Dermatology · 4
PDF
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy
2022 · Maria S. Asdourian, Nishi Shah, et al. · Journal of the American Academy of Dermatology · 4
PDF
Precautionary Behaviors and Breast Cancer-Related Lymphedema
2017 · Cheryl Brunelle, Meyha Swaroop, et al. · Lymphatic Research and Biology · 4
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation
2023 · Ted V Jacoby, Maria S Asdourian, et al. · Clinical and Experimental Dermatology · 3
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy
2022 · Ted V. Jacoby, Tracey S. Otto, et al. · British Journal of Dermatology · 3
Reply to J. Nudelman
2016 · Maria S. Asdourian, Melissa N. Skolny, et al. · Journal of Clinical Oncology · 3
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study
2022 · Maria S. Asdourian, Ted V. Jacoby, et al. · Journal of the American Academy of Dermatology · 2
PDF
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study
2024 · Rachel M. Reardon, Katherine L. Perlman, et al. · Journal of the American Academy of Dermatology · 1
PDF
Single Stage Permanent Implant Reconstruction Has Better Outcome Than Tissue Expander/Implant in Patients Treated with Postmastectomy Radiation
2017 · L.W. Salama, L.Z. Braunstein, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
In response to: Letter to the Editor by Kilbreath et al.
2016 · Meyha N. Swaroop, Cheryl L. Brunelle, et al. · Journal of Surgical Oncology · 1
506 Response to treatment of cutaneous immune-related adverse events following immune checkpoint inhibitor therapy
2023 · R.M. Reardon, K.L. Perlman, et al. · Journal of Investigative Dermatology
PDF
Works count: 42
Citation count: 849
H-index: 8
I10-index: 8
Year
Topic
Type